Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Identix (IDNX) -- Ignore unavailable to you. Want to Upgrade?

To: David who wrote (10233)	9/9/1998 12:14:00 PM
From: R. Jaynes	Read Replies (2) \| Respond to of 26039

David, I am not technically proficient so I have nothing to offer from that angle, but what evidence do we have that IDX can adapt itself to whatever standards come out of BioAPI? Is it just a matter of making some software changes or is it something more complicated than that? If they have to re-configure hardware it would seem to involve a lot more expense. If IDX can easily adapt to whatever API comes about then is this even such a big deal after all? Fowlers' ho-hum attitude about this seems to suggest there is not much reason to be concerned about API's. On the other hand, if API's are inevitable, shouldn't IDX be at the table to help guide the consortium towards standards which might be most advantageous for IDX? Perhaps this is an issue which could be brought up in a conference call or at the annual meeting. Rick